Explore finance insights with me! 📈💼 Disclaimer:Info provided is for educational purposes only. Consult a financial advisor before making investment decisions
10 things you can’t do with your bank, but can with @Wealthsimple 👇
1. Send a $50,000 Interac e-Transfer
2. Buy a car with Apple Pay and earn 2% cash back
3. Borrow up to 35% of your TFSA instantly and repay anytime
4. Get a chance to win $1,000,000 every month
5. Send money in 10 currencies
6. Get ATM fees reimbursed worldwide
7. Send physical cheques from your phone
8. Auto-invest your paycheque into crypto with 0% trading fees
9. Direct index entire markets and automatically tax-loss harvest
10. Deposit spare change into your chequing account at any Canada Post
Most of these didn’t exist 6 months ago. Product team is moving at an unreal pace 🏎️
I believe we will have a gold revaluation on July 4, 2026.
This includes #gold QE and bonds.
I decided to buy a lottery ticket and bet that the price of gold will be above $10,000 by July 17th, 2026.
For every $1,000 gold goes beyond $10,000, i make $12 million!
Not financial advice, just for fun! Whats a $20 gamble anyways!
Canada UPSETS USA and makes history winning their first gold medal at the FIBA U18 AmeriCup.
USA had won the last seven tournaments until now.
What a moment 🇨🇦
Home sales in Calgary declined in April compared with a year ago as the city’s real estate board says improved supply choice across the housing spectrum has reduced the urgency among potential buyers. https://t.co/MfeaQ7YeUt
I have no idea what $NFG.V is doing. But this is a big win for Dundee Corp., which backed Maritime from nanocap to takeout. Also an early backer of $NICU.V.
Combined with royalty revenue from Borborema, $DC-A.TO is flush and has recurring revenue to fund G&A.
Last call to register for our gene editing webinar!
Short reads and PCR bias can hide critical editing outcomes. Join us to see how amplification free #PacBio HiFi sequencing and PureTarget provide a complete view of #CRISPR edits.
Register here: https://t.co/Ds1IL1oifi
PACB target is hitting $3.15—a potential 100% upside!
Optimists are betting on the "Revio Revolution," sub-$300 genomes, and AI-driven efficiency to flip the script on the sequencing market. All eyes are on the May 7 earnings to prove the "burn" is fading. 🧬📈 #Genomics#PACB
The new SPRQ-Nx chemistry has slashed the cost of a high-fidelity genome to sub-$300, a massive 40% drop! By enabling multi-use SMRT cells and AI-driven efficiency, PacBio is moving long-read sequencing from elite labs to mainstream clinics.
Affordability meets accuracy #PACB